TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase

Annals of the New York Academy of Sciences

Volumn 995, Issue , 2003, Pages 22-38

  Lee, David C ^a   Sunnarborg, Susan Wohler ^a   Hinkle, C Leann ^a   Myers, Timothy J ^a   Stevenson, Mary ^b   Russell, William E ^b   Castner, Beverly J ^c   Gerhart, Mary J ^c   Paxton, Raymond J ^c   Black, Roy A ^c   Chang, Aileen ^a   Jackson, Leslie F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c AMGEN INC   (United States)

Author keywords

ADAM; EGF family; EGF receptor; ERBB; TACE ADAM17; TGF

Indexed keywords

AMPHIREGULIN; CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LIGAND; MEMBRANE PROTEIN; PROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; CELL LYSATE; CELL POPULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE DOSAGE; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; REDUCTION; REGULATORY MECHANISM;

ANIMALIA;

EID: 0038806501     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03207.x     Document Type: Conference Paper

References (47)

1. RIESE, D.J., II & D.F. STERN. 1998. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20: 41-48.
2. OLAYIOYE, M.A. et al. 2000. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19: 3159-3167.
3. GROENEN, L.C., E.C. NICE & A.W. BURGESS. 1994. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11: 235-257.
4. STEIN, R.A. & J.V. STAROS. 2000. Evolutionary analysis of the ErbB receptor and ligand families. J. Mol. Evol. 50: 397-412.
5. LEE, D.C. et al. 2003. EGF family ligands. In The Cytokine Handbook. Fourth Edition. Elsevier Science. Amsterdam/London/New York. In press.
6. JONES, J.T., R.W. AKITA & M.X. SLIWKOWSKI. 1999. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 447: 227-231.
7. BEERLI, R.R. et al. 1995. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol. 15: 6496-6505.
8. RIESE, D.J., II et al. 1995. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 15: 5770-5776.
9. PINKAS-KRAMARSKI, R. et al. 1996. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15: 2452-2467.
10. MASSAGUE, J. & A. PANDIELLA. 1993. Membrane-anchored growth factors. Annu. Rev. Biochem. 62: 515-541.
11. PESCHON, J.J. et al. 1998. An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284.
12. DERYNCK, R. et al. 1984. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell 38: 287-297.
13. LEE, D.C. et al. 1985. Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Nature 313: 489-491.
14. IGNOTZ, R.A. et al. 1986. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proc. Natl. Acad. Sci. USA 83: 6307-6311.
15. LUETTEKE, N.C. et al. 1988. Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells. Biochemistry 27: 6487-6494.
16. TEIXIDO, J. & J. MASSAGUE. 1988. Structural properties of a soluble bioactive precursor for transforming growth factor-alpha. J. Biol. Chem. 263: 3924-3929.
17. TEIXIDO, J. et al. 1990. Generation of transforming growth factor-alpha from the cell surface by an O-glycosylation-independent multistep process. J. Biol. Chem. 265: 6410-6415.
18. ARRIBAS, J. et al. 1996. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271: 11376-11382.
19. PANDIELLA, A. & J. MASSAGUE. 1991. Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. J. Biol. Chem. 266: 5769-5773.
20. BASELGA, J. et al. 1996. Autocrine regulation of membrane transforming growth factor-alpha cleavage. J. Biol. Chem. 271: 3279-3284.
21. BLACK, R.A. et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733.
22. Moss, M.L. et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385: 733-736.
23. SEALS, D.F. & S.A. COURTNEIDGE. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17: 7-30.
24. SUNNARBORG, S.W. et al. 2002. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277: 12838-12845.
25. BRILEY, G.P. et al. 1997. The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing. Mol. Biol. Cell 8: 1619-1631.
26. GOISHI, K. et al. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6: 967-980.
27. BERKOWITZ, E.A. et al. 1996. Characterization of the mouse transforming growth factor alpha gene: its expression during eyelid development and in waved 1 tissues. Cell Growth Differ. 7: 1271-1282.
28. LUETTEKE, N.C. et al. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750.
29. LUETTEKE, N.C. et al. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8: 399-413.
30. FOWLER, K.J. et al. 1995. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92: 1465-1469.
31. MERLOS-SUAREZ, A. et al. 2001. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J. Biol. Chem. 276: 48510-48517.
32. HINKLE, C.L. et al. 2003. Multiple metalloproteases process protransforming growth factor-α (proTGFα). Biochemistry 42: 2127-2136.
33. ZHAO, J. et al. 2001. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev. Biol. 232: 204-218.
34. IZUMI, Y. et al. 1998. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9, and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17: 7260-7272.
35. LEMJABBAR, H. & C. BASBAUM. 2002. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 8: 41-46.
36. YAN, Y., K. SHIRAKABE & Z. WERB. 2002. The metalloprotease Kuzbanian (ADAM 10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158: 221-226.
37. ASAKURA, M. et al. 2002. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8: 35-40.
38. Yu, W.H. et al. 2002. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16: 307-323.
39. BUXBAUM, J.D. et al. 1998. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273: 27765-27767.
40. SLACK, B.E., L.K. MA & C.C. SEAH. 2001. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. Biochem. J. 357: 787-794.
41. ROI, C. et al. 2000. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275: 10379-10387.
42. FRANZKE, C.W. et al. 2002. Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J. 21: 5026-5035.
43. DIAZ-RODRIGUEZ, E. et al. 2002. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 13: 2031-2044.
44. ZHENG, Y., J. SCHLONDORFF & C.P. BLOBEL. 2002. Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 277: 42463-42470.
45. REDDY, P. et al. 2000. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275: 14608-14614.
46. ANKLESARIA, P. et al. 1990. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc. Natl. Acad. Sci. USA 87: 3289-3293.
47. IWAMOTO, R., K. HANDA & E. MEKADA. 1999. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem. 274: 25906-25912.